戴文玲，女，副研究员，硕士研究生导师。2017年毕业于中国药科大学生药学专业，获博士学位；同年7月进入中国药科大学博士后流动站从事博士后研究。2020年博士后出站后留校任教。
研究方向：中药、天然产物有效部位及成分镇痛、抗吗啡耐受作用及机理研究。
主持承担国家自然科学基金青年基金项目(**)，中国博士后科学基金特别资助项目()，中国博士后科学基金面上资助项目()及中央高校培育项目（**PY12），并作为重要成员参与了科技部新药创制重大专项两项。以第一作者发表SCI论文多篇。
代表性论文：
Wen-Ling Dai,Bing Yan, Nan-Jiang, Juan-Juan Wu, Xiu-Feng Liu^*, Ji-Hua Liu^*, Bo-Yang Yu. Simultaneous inhibition of NMDA and mGlu1/5 receptors by levo-Corydalmine in rat spinal cord attenuates bone cancer pain, International Journal of Cancer. 2017, 141(4):805-815. (IF=7.360, top).
Wen-Ling Dai, Yi-Ni Bao, Ji-Fa Fan, Shan-Shan Li, Wan-Li Zhao, Bo-Yang Yu^*, Ji-Hua Liu^*. levo-Corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK/NF-κB signaling pathways in rat spinal cord,Regional Anesthesia and Pain Medicine. 2020, 45 (3): 219-229.(IF=7.015).
Wen-Ling Dai^&, Yi-Ni Bao^&, Ji-Fa Fan, Bin Ma, Shan-Shan Li, Wan-Li Zhao, Bo-Yang Yu*, Ji-Hua Liu*. Blockade of spinal dopamine D1/D2 receptor suppresses activation of NMDA receptor through Gαq and Src kinase to attenuate chronic bone cancer pain. Journal of Advanced Research. Accept. (IF= 6.992)
Wen-Ling Dai^&, Li Zhang^&, Liu Han^&, Xing Yang, Liang Hu, Chen Miao, Ling Song, Hang Xiao^*, Ji-Hua Liu^*, Wen-Tao Liu^*,Regulation of the K_ATP-JNK-gap junction signaling pathway by immunomodulator Astragaloside IVattenuates neuropathic pain. Regional Anesthesia and Pain Medicine. Accept. (IF= 7.015)
Wen-Ling Dai, Xin-Tong Liu, Yi-Ni Bao, Bing Yan, Nan Jiang, Bo-Yang Yu^*, Ji-Hua Liu^*. Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner. Experimental and Molecular Medicine. 2018, 50 (148). (IF= 4.743).
联系方式：
邮箱：daiwenlingdwl@163.com daiwenling@cpu.edu.cn